Poly Pid
Pharmaceuticals, Santa Clara, California, 95051, United States, 11-50 Employees
Phone Number: 97**********
Who is POLYPID
We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our ...
Read More

-
Headquarters: Santa Clara, California, 95051, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
CEO: Dikla Akselbrad
Industry: Pharmaceuticals
SIC Code: 3841
PolyPid Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PolyPid
Answer: PolyPid's headquarters are located at Santa Clara, California, 95051, United States
Answer: PolyPid's phone number is 97**********
Answer: PolyPid's official website is https://polypid.com
Answer: PolyPid's revenue is $10 Million to $25 Million
Answer: PolyPid's SIC: 3841
Answer: PolyPid has 11-50 employees
Answer: PolyPid is in Pharmaceuticals
Answer: PolyPid contact info: Phone number: 97********** Website: https://polypid.com
Answer: We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner. This allows surgeons to deliver medication right to the surgical site to improve patient outcomes in localized medical conditions such as; infection, pain, inflammation and cancer. Our initial infection treatment targets are Surgical Site Infections (SSIs), the second most prevalent type of Healthcare Acquired Infections (HAIs). SSIs have substantial negative impact on patients clinical outcomes and also pose a significant healthcare system burden. We strive to reduce overall surgical infection rates, including infections due to antibiotic-resistant bacteria which the FDA defined as being one of the worlds most pressing public health problems. NASDAQ: PYPD
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface

Sign in to CIENCE GO Data to uncover contact details
Free credits every month